The European Medicines Agency�s Committee for Medicinal Products for Human Use (CHMP) recommends the granting of a marketing authorisation for...
GE Healthcare has announced that the amyloid PET radiotracer F-18 flutemetamol (Vizamyl) has been given the CE mark from the...
The FDA has on 25 October 2013 approved Vizamyl (flutemetamol F 18 injection) from GE HealthCare Inc, a radioactive diagnostic...